Hemispheric infarction in a patient with an undiagnosed vasculopathy treated with aprotinin.
Eaton
Michael P
MP
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA. michael_eaton@urmc.rochester.edu
Alfieris
George M
GM
D007611:Aprotinin / Q000009:adverse effects* / Q000627:therapeutic use; D001919:Bradycardia / Q000209:etiology; D001921:Brain / Q000098:blood supply* / Q000000981:diagnostic imaging; D002315:Cardiopulmonary Bypass / Q000009:adverse effects / Q000379:methods; D002339:Carotid Arteries / Q000002:abnormalities* / Q000473:pathology; D002341:Carotid Artery Thrombosis / Q000150:complications* / Q000473:pathology; D002544:Cerebral Infarction / Q000175:diagnosis / Q000209:etiology*; D002648:Child; D017809:Fatal Outcome; D005260:Female; D006330:Heart Defects, Congenital / Q000601:surgery; D006490:Hemostatics / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007427:Intracranial Pressure / Q000502:physiology; D011183:Postoperative Complications / Q000175:diagnosis / Q000209:etiology; D012086:Reoperation; D012640:Seizures / Q000209:etiology; D013927:Thrombosis / Q000150:complications; D014057:Tomography, X-Ray Computed
D006490:Hemostatics; D007611:Aprotinin